景瑞(01862.HK)一系列優先票據獲同意落實進行建議修訂
景瑞控股(01862.HK)公佈,有關尚未償付之2022年7月到期12釐優先票據、2022年9月到期12釐優先票據、2023年2月到期14.5釐優先票據、2023年10月到期12.5釐優先票據及2024年1月到期12釐優先票據的同意徵求,於倫敦時間(1日)已屆滿,公司已獲得必要同意以落實對各契約進行建議修訂。
公司指出,由於已獲得必要同意,公司及附屬擔保人擬於切實可行的情況下儘快與相關受託人就各契約籤立補充契約,以落實建議修訂。目前預期將於3月9日支付任何到期的同意費,惟須待同意徵求得以實現及支付同意費的條件獲達成後方會支付。
此外,就2022年3月到期12.75釐優先票據的交換要約期限,由倫敦時間昨日延長至3月4日下午4時正,即時生效。票據合資格持有人交付交換代價預期將於3月9日或前後進行,而新票據預期將於3月10日或前後在新加坡交易所上市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.